-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029

PUBT·08/03/2026 22:15:10
Listen to the news
Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029
  • Contineum Therapeutics CEO and President Carmine N. Stengone sold 2,500 Class A common shares at USD 16.01 on Aug. 3, 2026.
  • He acquired 2,500 Class A common shares at USD 1.01 via option exercise the same day.
  • Directly held Class A common shares fell to 17,217 from 19,717.
  • Stock options beneficially owned declined to 276,930 from 279,430.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-052031), on August 03, 2026, and is solely responsible for the information contained therein.